aluates Reports

$ 0.0

Automative

Global Decentralized Clinical Trials (DCTs) Market Research Report 2026

Published Date: 2026-04-10

Report Code: QYRE-Auto-28Z8729

Global Decentralized Clinical Trials DCTs Market Insights and Forecast to 2028

BUY CHAPTERS

Global Decentralized Clinical Trials (DCTs) Market Research Report 2026

Code: QYRE-Auto-28Z8729

Report

2026-04-10

Pages:117

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medidata

IQVIA

PRA Health Sciences

ICON

Oracle

CRF Health

Clinical Ink

Medable

Science 37

PAREXEL

LabCorp

Decentralized Clinical Trials (DCTs) Market Size

The global Decentralized Clinical Trials (DCTs) market was valued at US$ 10630 million in 2025 and is anticipated to reach US$ 27580 million by 2032, at a CAGR of 14.8% from 2026 to 2032.

Decentralized Clinical Trials (DCTs) Market

The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model. Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.

The decentralized clinical trials (DCT) market is driven by the growing need for patient-centric trial designs that improve accessibility and convenience. By leveraging technology such as telemedicine, wearables, and remote monitoring, DCTs allow patients to participate from their homes, reducing the burden of travel and time commitments. This not only enhances patient recruitment and retention rates but also enables trials to include more diverse and geographically dispersed populations, ultimately accelerating the drug development process. However, a significant challenge in the decentralized clinical trials market is the integration of complex digital tools and data management systems. Ensuring the seamless and secure transfer of patient data across various platforms requires significant investment in infrastructure and poses privacy concerns. Additionally, regulatory frameworks for DCTs are still evolving, and inconsistencies in approval processes across regions can create barriers for global trial implementation. Ensuring patient compliance and maintaining trial integrity in a remote setting also add layers of complexity to trial management.

Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%. North America is the largest sales region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.

This report delivers a comprehensive overview of the global Decentralized Clinical Trials (DCTs) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Decentralized Clinical Trials (DCTs). The Decentralized Clinical Trials (DCTs) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Decentralized Clinical Trials (DCTs) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Decentralized Clinical Trials (DCTs) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Decentralized Clinical Trials (DCTs) Market Report

Report Metric	Details
Report Name	Decentralized Clinical Trials (DCTs) Market
Accounted market size in 2025	US$ 10630 million
Forecasted market size in 2032	US$ 27580 million
CAGR	14.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Interventional Observational Expanded Access
Segment by Application	Oncology Cardiovascular Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Decentralized Clinical Trials (DCTs) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Decentralized Clinical Trials (DCTs) Market growing?

Ans: The Decentralized Clinical Trials (DCTs) Market witnessing a CAGR of 14.8% during the forecast period 2026-2032.

What is the Decentralized Clinical Trials (DCTs) Market size in 2032?

Ans: The Decentralized Clinical Trials (DCTs) Market size in 2032 will be US$ 27580 million.

What is the market share of major companies in Decentralized Clinical Trials (DCTs) Market?

Ans: Global top five manufacturers hold a share over 45%.

What is the Decentralized Clinical Trials (DCTs) Market share by type?

Ans: In terms of product, Interventional is the largest segment, with a share over 45%.

Who are the main players in the Decentralized Clinical Trials (DCTs) Market report?

Ans: The main players in the Decentralized Clinical Trials (DCTs) Market are Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, ICON, Oracle, CRF Health, Clinical Ink, Medable, Science 37

What are the Application segmentation covered in the Decentralized Clinical Trials (DCTs) Market report?

Ans: The Applications covered in the Decentralized Clinical Trials (DCTs) Market report are Oncology, Cardiovascular, Others

What are the Type segmentation covered in the Decentralized Clinical Trials (DCTs) Market report?

Ans: The Types covered in the Decentralized Clinical Trials (DCTs) Market report are Interventional, Observational, Expanded Access

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Interventional

1.2.3 Observational

1.2.4 Expanded Access

1.3 Market by Application

1.3.1 Global Decentralized Clinical Trials (DCTs) Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2021–2032)

2.2 Global Decentralized Clinical Trials (DCTs) Growth Trends by Region

2.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Decentralized Clinical Trials (DCTs) Historic Market Size by Region (2021–2026)

2.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2027–2032)

2.3 Decentralized Clinical Trials (DCTs) Market Dynamics

2.3.1 Decentralized Clinical Trials (DCTs) Industry Trends

2.3.2 Decentralized Clinical Trials (DCTs) Market Drivers

2.3.3 Decentralized Clinical Trials (DCTs) Market Challenges

2.3.4 Decentralized Clinical Trials (DCTs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue

3.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2021–2026)

3.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2021–2026)

3.2 Global Top Decentralized Clinical Trials (DCTs) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Decentralized Clinical Trials (DCTs) Revenue

3.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio

3.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2025

3.5 Global Key Players of Decentralized Clinical Trials (DCTs) Head Offices and Areas Served

3.6 Global Key Players of Decentralized Clinical Trials (DCTs), Products and Applications

3.7 Global Key Players of Decentralized Clinical Trials (DCTs), Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Decentralized Clinical Trials (DCTs) Breakdown Data by Type

4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2021–2026)

4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2027–2032)

5 Decentralized Clinical Trials (DCTs) Breakdown Data by Application

5.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2021–2026)

5.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Decentralized Clinical Trials (DCTs) Market Size (2021–2032)

6.2 North America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2021–2026)

6.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2021–2032)

7.2 Europe Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2021–2026)

7.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2021–2032)

8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2021–2026)

8.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2021–2032)

9.2 Latin America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2021–2026)

9.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2021–2032)

10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2021–2026)

10.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medidata

11.1.1 Medidata Company Details

11.1.2 Medidata Business Overview

11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction

11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.1.5 Medidata Recent Development

11.2 IQVIA

11.2.1 IQVIA Company Details

11.2.2 IQVIA Business Overview

11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction

11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.2.5 IQVIA Recent Development

11.3 Labcorp

11.3.1 Labcorp Company Details

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction

11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.3.5 Labcorp Recent Development

11.4 PRA Health Sciences

11.4.1 PRA Health Sciences Company Details

11.4.2 PRA Health Sciences Business Overview

11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction

11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.4.5 PRA Health Sciences Recent Development

11.5 Parexel

11.5.1 Parexel Company Details

11.5.2 Parexel Business Overview

11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction

11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.5.5 Parexel Recent Development

11.6 ICON

11.6.1 ICON Company Details

11.6.2 ICON Business Overview

11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction

11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.6.5 ICON Recent Development

11.7 Oracle

11.7.1 Oracle Company Details

11.7.2 Oracle Business Overview

11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction

11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.7.5 Oracle Recent Development

11.8 CRF Health

11.8.1 CRF Health Company Details

11.8.2 CRF Health Business Overview

11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction

11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.8.5 CRF Health Recent Development

11.9 Clinical Ink

11.9.1 Clinical Ink Company Details

11.9.2 Clinical Ink Business Overview

11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction

11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.9.5 Clinical Ink Recent Development

11.10 Medable

11.10.1 Medable Company Details

11.10.2 Medable Business Overview

11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction

11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.10.5 Medable Recent Development

11.11 Science 37

11.11.1 Science 37 Company Details

11.11.2 Science 37 Business Overview

11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction

11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2021–2026)

11.11.5 Science 37 Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Medidata

IQVIA

PRA Health Sciences

ICON

Oracle

CRF Health

Clinical Ink

Medable

Science 37

PAREXEL

LabCorp

List of Tables

Table 1. Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Interventional

Table 3. Key Players of Observational

Table 4. Key Players of Expanded Access

Table 5. Global Decentralized Clinical Trials (DCTs) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 7. Global Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million), 2021–2026

Table 8. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2021–2026)

Table 9. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (US$ Million), 2027–2032

Table 10. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2027–2032)

Table 11. Decentralized Clinical Trials (DCTs) Market Trends

Table 12. Decentralized Clinical Trials (DCTs) Market Drivers

Table 13. Decentralized Clinical Trials (DCTs) Market Challenges

Table 14. Decentralized Clinical Trials (DCTs) Market Restraints

Table 15. Global Decentralized Clinical Trials (DCTs) Revenue by Players (US$ Million), 2021–2026

Table 16. Global Decentralized Clinical Trials (DCTs) Market Share by Players (2021–2026)

Table 17. Global Top Decentralized Clinical Trials (DCTs) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Decentralized Clinical Trials (DCTs) Revenue, 2025

Table 18. Ranking of Global Top Decentralized Clinical Trials (DCTs) Companies by Revenue (US$ Million) in 2025

Table 19. Global 5 Largest Players Market Share by Decentralized Clinical Trials (DCTs) Revenue (CR5 and HHI), 2021–2026

Table 20. Global Key Players of Decentralized Clinical Trials (DCTs), Headquarters and Area Served

Table 21. Global Key Players of Decentralized Clinical Trials (DCTs), Products and Applications

Table 22. Global Key Players of Decentralized Clinical Trials (DCTs), Date of General Availability (GA)

Table 23. Mergers and Acquisitions, Expansion Plans

Table 24. Global Decentralized Clinical Trials (DCTs) Market Size by Type (US$ Million), 2021–2026

Table 25. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2021–2026)

Table 26. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (US$ Million), 2027–2032

Table 27. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2027–2032)

Table 28. Global Decentralized Clinical Trials (DCTs) Market Size by Application (US$ Million), 2021–2026

Table 29. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2021–2026)

Table 30. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (US$ Million), 2027–2032

Table 31. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2027–2032)

Table 32. North America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 33. North America Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2021–2026

Table 34. North America Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2027–2032

Table 35. Europe Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 36. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2021–2026

Table 37. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2027–2032

Table 38. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 39. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million), 2021–2026

Table 40. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million), 2027–2032

Table 41. Latin America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2021–2026

Table 43. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2027–2032

Table 44. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2021–2026

Table 46. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (US$ Million), 2027–2032

Table 47. Medidata Company Details

Table 48. Medidata Business Overview

Table 49. Medidata Decentralized Clinical Trials (DCTs) Product

Table 50. Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 51. Medidata Recent Development

Table 52. IQVIA Company Details

Table 53. IQVIA Business Overview

Table 54. IQVIA Decentralized Clinical Trials (DCTs) Product

Table 55. IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 56. IQVIA Recent Development

Table 57. Labcorp Company Details

Table 58. Labcorp Business Overview

Table 59. Labcorp Decentralized Clinical Trials (DCTs) Product

Table 60. Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 61. Labcorp Recent Development

Table 62. PRA Health Sciences Company Details

Table 63. PRA Health Sciences Business Overview

Table 64. PRA Health Sciences Decentralized Clinical Trials (DCTs) Product

Table 65. PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 66. PRA Health Sciences Recent Development

Table 67. Parexel Company Details

Table 68. Parexel Business Overview

Table 69. Parexel Decentralized Clinical Trials (DCTs) Product

Table 70. Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 71. Parexel Recent Development

Table 72. ICON Company Details

Table 73. ICON Business Overview

Table 74. ICON Decentralized Clinical Trials (DCTs) Product

Table 75. ICON Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 76. ICON Recent Development

Table 77. Oracle Company Details

Table 78. Oracle Business Overview

Table 79. Oracle Decentralized Clinical Trials (DCTs) Product

Table 80. Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 81. Oracle Recent Development

Table 82. CRF Health Company Details

Table 83. CRF Health Business Overview

Table 84. CRF Health Decentralized Clinical Trials (DCTs) Product

Table 85. CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 86. CRF Health Recent Development

Table 87. Clinical Ink Company Details

Table 88. Clinical Ink Business Overview

Table 89. Clinical Ink Decentralized Clinical Trials (DCTs) Product

Table 90. Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 91. Clinical Ink Recent Development

Table 92. Medable Company Details

Table 93. Medable Business Overview

Table 94. Medable Decentralized Clinical Trials (DCTs) Product

Table 95. Medable Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 96. Medable Recent Development

Table 97. Science 37 Company Details

Table 98. Science 37 Business Overview

Table 99. Science 37 Decentralized Clinical Trials (DCTs) Product

Table 100. Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (US$ Million), 2021–2026

Table 101. Science 37 Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. Decentralized Clinical Trials (DCTs) Picture

Figure 2. Global Decentralized Clinical Trials (DCTs) Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Decentralized Clinical Trials (DCTs) Market Share by Type: 2025 vs 2032

Figure 4. Interventional Features

Figure 5. Observational Features

Figure 6. Expanded Access Features

Figure 7. Global Decentralized Clinical Trials (DCTs) Market Size by Application (US$ Million), 2021–2032

Figure 8. Global Decentralized Clinical Trials (DCTs) Market Share by Application: 2025 vs 2032

Figure 9. Oncology Case Studies

Figure 10. Cardiovascular Case Studies

Figure 11. Others Case Studies

Figure 12. Decentralized Clinical Trials (DCTs) Report Years Considered

Figure 13. Global Decentralized Clinical Trials (DCTs) Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Decentralized Clinical Trials (DCTs) Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Decentralized Clinical Trials (DCTs) Market Share by Region: 2025 vs 2032

Figure 16. Global Decentralized Clinical Trials (DCTs) Market Share by Players in 2025

Figure 17. Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Decentralized Clinical Trials (DCTs) Revenue in 2025

Figure 19. North America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Decentralized Clinical Trials (DCTs) Market Share by Country (2021–2032)

Figure 21. United States Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Decentralized Clinical Trials (DCTs) Market Share by Country (2021–2032)

Figure 25. Germany Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Share by Region (2021–2032)

Figure 33. China Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Decentralized Clinical Trials (DCTs) Market Share by Country (2021–2032)

Figure 41. Mexico Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Share by Country (2021–2032)

Figure 45. Israel Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Decentralized Clinical Trials (DCTs) Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Medidata Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 49. IQVIA Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 50. Labcorp Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 51. PRA Health Sciences Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 52. Parexel Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 53. ICON Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 54. Oracle Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 55. CRF Health Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 56. Clinical Ink Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 57. Medable Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 58. Science 37 Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2021–2026)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Decentralized Clinical Trial Solution Market Research Report 2024

Global Remote Clinical Trials Market Research Report 2024

Global Virtual Clinical Trials Market Research Report 2024

Global Decentralized Clinical Trial Software Market Research Report 2024

Global Clinical Trial Digitalization Market Research Report 2025

Global Medical Devices Clinical Trials Market Research Report 2025

Global eConsent in Clinical Trials Market Research Report 2024

Global Clinical Trial Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Imaging In Clinical Trials Market Research Report 2024

Global Offshoring Clinical Trials Market Research Report 2024

Global E Clinical Software Market Research Report 2024

Global Cloud Computing in Clinical Trials Market Research Report 2024

Global Clinical Trial Imaging Market Research Report 2024

Global Clinical Trial Investigative Site Network Market Research Report 2024

Global Clinical Trial Translation Service Market Research Report 2024

Global Clinical Trial Platform Market Research Report 2025

Global Oncology Clinical Trial Market Research Report 2024

Global Telehealth and Telemedicine Market Research Report 2025

E Clinical Solution Software

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions